CEVA, Inc. (NASDAQ: CEVA), the leading licensor of signal processing IP for smarter, connected devices, announced today that CEVA management will participate in the following upcoming conferences:...

Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics focused on the gut microbiome, today announced that members of Synthetic Biologics' executive...

WidePoint Corporation (NYSE Mkt: WYY) a leading provider of Managed Mobility Services (MMS) specializing in Cybersecurity and Telecommunications Lifecycle Management (TLM) solutions, today...

Tech industry giants, entrepreneurs, thought leaders and more will soon gather from around the world at CES® 2017, the center of innovation for the past 50 years. With 3,800+ exhibiting companies...

Tech industry giants, entrepreneurs, thought leaders and more will soon gather from around the world at CES® 2017, the center of innovation for the past 50 years. With 3,800+ exhibiting companies...

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that Richard Slansky, OncoSec's Chief Financial...

PATTERSON-UTI ENERGY, INC. (NASDAQ: PTEN) today announced that it will make a presentation on December 7, 2016 at the Cowen and Company Energy & Natural Resources Conference. Representing the...

Shionogi & Co., Ltd. (hereafter "Shionogi") presented additional clinical data from a Phase 2 proof-of-concept study for S-033188, a cap-dependent endonuclease inhibitor targeting influenza. The...

The Group observes 90 years since founding and 20 years of exhibiting at conference Introduces “One Guerbet” exhibit Princeton, NJ, November 30, 2016 – Guerbet (FR0000032526 GBT), the global...

Over the past two days, Puerto Rico was the hub for life sciences activity at Biolatam® 2016, in which more than 250 leaders from the biotech, pharmaceutical and technology industry came together...